Market Overview

Ventrus Announces Public Offerings of Stock, Series A Convertible Preferred Stock

Related VTUS
Morning Market Movers
UPDATE: Cantor Fitzgerald Lowers PT on Ventrus Biosciences on 4Q Earnings Report

Ventrus Biosciences, Inc. (Nasdaq: VTUS) announced today that it is concurrently offering to sell, subject to market and other conditions, (i) shares of its common stock in an underwritten public offering, and (ii) shares of its Series A Convertible Preferred Stock ("Series A") in a separate underwritten public offering. The Series A is non-voting and each share of Series A is convertible into 10 shares of Ventrus common stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would own more than 9.98% of the total number of Ventrus shares of common stock then outstanding. All of the shares in these offerings are to be sold by Ventrus. Ventrus also intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the common stock public offering to cover over-allotments, if any.

Posted-In: News Offerings

 

Most Popular

Related Articles (VTUS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free